808732-98-1
808732-98-1
Chemical Structure
Rislenemdaz
Synonym(s): MK-0657; CERC-301
- CAS No.: 808732-98-1
- Formula:C19H23FN4O2
- Molecular Weight:358.41
IUPAC Name: 4-methylbenzyl (3S,4R)-3-fluoro-4-((pyrimidin-2-ylamino)methyl)piperidine-1-carboxylate
InChIKey: RECBFDWSXWAXHY-IAGOWNOFSA-N
SMILES: O=C(N1C[C@@H](F)[C@@H](CNC2=NC=CC=N2)CC1)OCC3=CC=C(C)C=C3
Biological Activity: Rislenemdaz (CERC-301) is an orally bioavailable and selective N-methyl-D-aspartate (NMDA) receptor subunit 2B (GluN2B) antagonist with Ki and IC 50 of 8.1 nM and 3.6 nM, respectively.
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Rislenemdaz | 99.86% | Rislenemdaz (CERC-301) is an orally bioavailable and selective N-methyl-D-aspartate (NMDA) receptor subunit 2B (GluN2B) antagonist with Ki and IC 50 of 8.1 nM and 3.6 nM, respectively. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Rislenemdaz (Standard) | ≥98% | Rislenemdaz (Standard) is the analytical standard of Rislenemdaz (HY-106441A). This product is intended for research and analytical applications. Rislenemdaz (CERC-301) is an orally bioavailable and selective N-methyl-D-aspartate (NMDA) receptor subunit 2B (GluN2B) antagonist with Ki and IC 50 of 8.1 nM and 3.6 nM, respectively. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
